Longitude Capital Partners III, LLC - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
800 El Camino, Suite 220, Menlo Park, California
-
Summary
-
The estimated value of insider holdings of Longitude Capital Partners III, LLC is at least $70.1M dollars as of April 29, 2022. Longitude Capital Partners III, LLC is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $54.7M. Longitude Capital Partners III, LLC is the 10%+ Owner of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $14.9M. Longitude Capital Partners III, LLC is the 10%+ Owner of Sierra Oncology, Inc. and owns shares of Sierra Oncology, Inc. stock worth about $441K.